CN101982194A - Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes - Google Patents
Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes Download PDFInfo
- Publication number
- CN101982194A CN101982194A CN 201010547697 CN201010547697A CN101982194A CN 101982194 A CN101982194 A CN 101982194A CN 201010547697 CN201010547697 CN 201010547697 CN 201010547697 A CN201010547697 A CN 201010547697A CN 101982194 A CN101982194 A CN 101982194A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- compound preparation
- diabetes
- extracting solution
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a traditional Chinese medicine compound preparation for treating dampness-heat spleen encumbering type diabetes, which comprises the following components of 1-90% of Mongolian snakegourd root, 0.1-60% of grassleaf sweelflag rhizome, 0.1-40% of coptis root, 0.1-40% of round cardamom, 0-40% of coix seed, 0-40% of wrinkled gianthyssop herb, 0-40% of atractylodes rhizome, 0-40% of officinal magnolia bark, 0-40% of alisma rhizome and the like. The preparation method of the compound preparation comprises the following steps: crushing the raw materials into fine powder and pelleting; or carrying out reflux extraction with medicinal alcohol (or water) for 10 to 120 minutes, filtering to obtain extracting solution, concentrating until being dry, encapsuling or tabletting or pelleting; or concentrating the extracting solution into a half of the volume of the raw medicinal materials, sterilizing and bottling. The product is taken according to 1-50g or 5-20ml of the concentrated solution per person per day and has obvious blood sugar reduction effect.
Description
Technical field
The invention belongs to Chinese herbal compound preparation, be specifically related to a kind of compound Chinese medicinal preparation for the treatment of damp and hot tired spleen type diabetes.
Background technology
Diabetes have become the significant problem that threatens human health.The number of China's diabetics ranks first in the world, and it is surprising to gather way: about 8,000 ten thousand people of China's diabetes (containing hyperglycemia) patient sum according to the preliminary statistics are mainly type 2 diabetes mellitus; China's type 2 diabetes mellitus sickness rate in 1979 only is that 1.00%, 1994 year prevalence has risen to 2.5%, has broken through 5% at present.The advantage of performance Chinese medicine is made an effort for the prevention and the treatment of diabetes, is the huge contribution to the mankind.
Radix Trichosanthis is the cucurbitaceous plant Fructus Trichosanthis
Trichosanthes kirilowiiMaxim. or trichosanthes rosthornii Harms
Trichosanthes rosthorniiThe dry root of Harms, sweet, the little hardship of property, be slightly cold, attach to the lung and stomach meridians, have effects such as clearing heat, purging intense-heat, promoting the production of body fluid to quench thirst, detumescence and apocenosis, be used for calentura excessive thirst, lung-heat type cough, interior-heat quench one's thirst (diabetes), sore swollen toxin (" 2010 editions one one 52 pages of Chinese pharmacopoeia).The main component of Radix Trichosanthis be protein, starch, lectins, polysaccharide, saponin etc. (Li Zhenhong, Lu Yang, Liu Jingxing. Radix Trichosanthis chemical constituent and pharmacologically active [J]. external medical plant amedica fascicle, 2003,18(1): 1-4); Its lectins (Radix Trichosanthis agglutinin) have that the lipotropism fat decomposes and promote ILA such as lipogenesis (Chou Weixin. Radix Trichosanthis pharmaceutical research progress [J]. Chinese Chinese medicine information magazine, 1996,3(6): 11-13), have hypoglycemic activity; The Japan scholar is also isolating to a plurality of hypoglycemic activity composition (Hikino H from Radix Trichosanthis, et al. Isolation and hypoglycemic activity of trichosans A, B, C, D and E:glycans of Trichosanthes kirilowii roots. Planta Medica, 1989,55 (4): 349).In the ancient prescription of Chinese medicine, Radix Trichosanthis is in a large number as hypoglycemic medicine (Zhou Jun, Feng Yan. the period of Ming and Qing medical record 59 routine medication statistical analysiss [J] of quenching one's thirst. traditional Chinese medical science forum, 2005,20 (6): 18), and frequency of utilization very high (Zheng Hong. the prescription compatibility The law [J] of Chinese traditional treatment diabetes. Shandong Traditional Chinese Medicine University's journal, 2008,32 (4): 286); Variola is divided the medicine as treatment diabetes (diabetes), for middle slake diabetes due to kidney-deficiency all have better curative effect (Sun Fenglei, high China. Compendium of Material Medica treatment diabetes medicine simple analysis [J]. Liaoning Journal of Traditional Chinese Medicine, 2003,30 (2): 83).
Rhizoma Coptidis is the ranunculaceae plant Rhizoma Coptidis
Coptis chinensisFranch
., Coptis deltoidea C.Y.Cheng et Hsiao
Coptis deltoidea C. Y.Cheng et Hsiao or Coptis Teeta Wall
Coptis teetaWall
.Dry rhizome, the property hardship, cold, GUIXIN, spleen, stomach, liver, gallbladder, large intestine channel have the effect of heat clearing and damp drying, eliminating fire and detoxication, all diseases such as be used to quench one's thirst (diabetes), damp and hot feeling of fullness, vomiting acid regurgitation, dysentery (" 2010 editions one one 285 pages of Chinese pharmacopoeia).The main active of Rhizoma Coptidis is berberine Rhizoma Coptidis alkaloids such as (BBR).BBR has blood sugar lowering, correct lipid metabolic disorder, reduce body weight, improve function such as insulin resistant (appoint firm, Yang Jing.Berberine is treated the progress of 2 type diabetes mechanism of action.Combination of Chinese and Western medicine cardiovascular and cerebrovascular disease magazine, 2008,6(2): 208～210); BBR can increase the HepG2 cell to the consumption of glucose, suppress cell (3T3-L1) before the fat differentiation, increase HepG2 cell surface low density lipoprotein receptor (LDLR) content, suppress the lipogenesis enzyme activity, increase adipose cell secretion adiponectin and suppress the secretion etc. of leptin, thereby show good hypoglycemic activity (appoint firm, Yang Jing.Berberine is treated the progress of 2 type diabetes mechanism of action.Combination of Chinese and Western medicine cardiovascular and cerebrovascular disease magazine, 2008,6(2): 208～210); BBR can suppress the adipose cell differentiation, can lose weight and blood fat reducing when improving insulin resistant, and its blood sugar reducing function does not rely on the release of insulin and summation action is arranged, and has unique mechanism and curative effect in correcting glycolipid metabolism.Therefore, Rhizoma Coptidis and active component thereof (BBR) are the natural drugs of more satisfactory treatment diabetes.
Rhizoma Acori Graminei is an acorus gramineus araceae plant
Acorus tatarinowiiThe dry rhizome of Schott, property suffering, hardship, temperature, GUIXIN, stomach warp have effects such as the eliminating phlegm of having one's ideas straightened out, refreshment Fructus Alpiniae Oxyphyllae, removing dampness appetizing, are used for that coma epilepsy, forgetful insomnia, Hiccough and deaf, gastral cavity painful abdominal mass are not hungry, mouthful dysentery of keeping silent (" 2010 editions one one 85 pages of Chinese pharmacopoeia).The main active of Rhizoma Acori Graminei is a volatile oil, comprises that (Li Ji comes materials such as beta-Asarone, α-asaricin, Chen Feilong, He Feng, Deng. the comparative study [J] of the GC of Rhizoma Acori Graminei volatile oil composition-MS analysis and Different Extraction Method. Chinese crude drug, 2001,24 (7): 494 – 495).Rhizoma Acori Graminei and active component thereof are used to data cardiovascular disease (Wu Qiduan.The pharmacodynamic study and the mechanism of Rhizoma Acori Graminei volatile oil and beta-Asarone control acute myocardial infarction are inquired into.Traditional Chinese Medicine University Of Guangzhou's master thesis.2006）。
Fructus Amomi Rotundus is the zingiberaceous plant Fructus Amomi Rotundus
Amomum kravanhPierre ex Gagnep. or melon Fructus Amomi Rotundus
Amomum compactumThe dry mature fruit of Soland ex Maton..The property suffering, temperature is returned lung, spleen, stomach warp, has the removing dampness circulation of qi promoting, warming middle-JIAO to arrest vomiting, the effect of appetite-stimulating indigestion-relieving.The effective ingredient of Fructus Amomi Rotundus has volatility or sublimability (Liu's generaI investigation, Zhao Haifeng, Song Yijun, Ji Defu, Hou Minna.Fructus Amomi Rotundus volatile oil Study on extraction.The ShanXi Chinese Medicine Academy journal, 2007,30(5): 75～77).
The traditional Chinese medical science is divided into type in 5 (" study of tcm new drug clinical guidance principle " with " diabetes " (diabetes), 2003): intense heat due to deficiency of YIN card (dry mouth and throat, vexed fear heat), damp and hot tired spleen is demonstrate,proved (breast gastral cavity abdominal distention, or the food back is full, heaviness sensation over the head and body), syndrome of deficiency of both qi and yin (dry mouth and throat, fatigue and weakness), deficiency syndrome of both YIN and YANG and blood stasis causing water retention card (spiritlessness and weakness, dry mouth and throat, the acid of waist knee joint is cold, or brothers' fear of cold, nocturia), blood stasis venation card (chest pain, hypochondriac pain, lumbago, backache, the position is fixed, or is twinge, numb limbs and tense tendons, pain night is very) etc.The compound recipe that Chinese medicine is used for the treatment of diabetes is a lot, and the Chinese medicine preparation that is used for the treatment of 4 type diabetess such as " intense heat due to deficiency of YIN ", " deficiency of both QI and YIN ", " deficiency of both YIN and YANG ", " blood stasis venation " is more, and the Chinese medicine preparation of treatment " damp and hot tired spleen " type diabetes is few.
This method is based on the ancient prescription " Rhizoma Acori Graminei looses " (" Shengji Zonglu " volume 59 " Rhizoma Acori Graminei looses ": Rhizoma Acori Graminei one or two, two liang of RADIX TRICHOSANTHISs, Rhizoma Coptidis half two) of treatment " diabetes ", add Fructus Amomi Rotundus with removing dampness circulation of qi promoting effect, to strengthen the effect (Radix Trichosanthis, Rhizoma Coptidis, Rhizoma Acori Graminei, the Radix Aucklandiae) of the compound recipe for the treatment of " damp and hot tired spleen " type diabetes, do not appear in the newspapers as yet.
Summary of the invention
The objective of the invention is at the prior art defective, a kind of Rhizoma Coptidis compound preparation for the treatment of damp and hot tired spleen type diabetes is provided.
The Chinese medicine compound of this treatment diabetes comprises the raw material of Chinese medicine of following percentage by weight: Radix Trichosanthis 1～90%, Rhizoma Acori Graminei 0.1～60%, Rhizoma Coptidis 0.1～40%, Fructus Amomi Rotundus 0.1～40%, Semen Coicis 0～40%, Herba Pogostemonis 0～40%, Rhizoma Atractylodis 0～40%, Cortex Magnoliae Officinalis 0～40%, Rhizoma Alismatis 0～40%.
Preferred compositions is following raw materials by weight percent in the described preparation: Radix Trichosanthis 30～80%, Rhizoma Acori Graminei 5～40%, Rhizoma Coptidis 5～40%, Fructus Amomi Rotundus 5～40%.
It is prepared as follows: above-mentioned raw materials is added on together in proportion, is ground into the fine powder pill; Perhaps use medicinal ethanol (or water) to decoct 10～120 minutes, filter and obtain extracting solution, be concentrated into driedly, encapsulated or tabletting gets final product; Or extracting solution is concentrated into 1/2 of raw material volume, sterilization bottling then.This product according to for each person every day 1～50 the gram or concentrated solution take for 5～20 milliliters, have the obvious functions of blood sugar effect.
Among the present invention, Radix Trichosanthis and Rhizoma Coptidis have very strong hypoglycemic activity, are the main hypoglycemic activity composition of this product.Rhizoma Acori Graminei and Fructus Amomi Rotundus have the damp and hot effect of removing, and strengthen the function of preparation clearing away damp-heat, and then strengthen the effect that its treatment " is quenched one's thirst ".
The effect that below is this compound product treatment diabetes compares.
The preparation of experiment medicine: Radix Trichosanthis 15g, Rhizoma Acori Graminei 4g, Rhizoma Coptidis 2g, Fructus Amomi Rotundus 3g.Above-mentioned raw materials is added on together, extracted 60 minutes, filter and obtain extracting solution with medicinal reflow of alcohol, 1/2nd (12 milliliters) of simmer down to Chinese crude drug raw material volume, standby.
Control drug 1(does not contain Fructus Amomi Rotundus) preparation: Radix Trichosanthis 15g, Rhizoma Acori Graminei 4g, Rhizoma Coptidis 2g.Above-mentioned raw materials is added on together, extracted 60 minutes, filter and obtain extracting solution with medicinal reflow of alcohol, 1/2nd (10.5 milliliters) of simmer down to Chinese crude drug raw material volume, standby.
The blood sugar lowering experiment: choose 100 of clean level mices, balance was fed after 3 days, tail vein injection alloxan; After 3 days, get blood measuring blood glucose.The mice of choosing blood glucose value and be 10～25 μ mle/mL is a modeling success mice, and the mice with the modeling success is divided into four groups (10 every group) then.One group is high sugared model control group, irritates and feeds distilled water (matched group); One group of positive medicine matched group (acarbose) is irritated and is fed acarbose medicine (10mg/Kg); One group is 1 group of control drug, irritates and feeds trial drug (1mL/Kg); One group is compound antihypelipidemic medicine group, irritates and feeds trial drug (1mL/Kg); Continuous irrigation was fed after 30 days, measured blood sugar content (table 1) in the blood.
Table 1, blood sugar lowering experimental result
| ? | Post-prandial glycemia ( μmle/mL） | Fasting glucose ( μmle/mL） | Dead number of elements (only) |
| Normal group | 10.42±1.45 | 5.34±0.91 | 0 |
| High sugared matched group | 23.44±3.22 | 14.33±2.99 | 2 |
| The acarbose group | 15.12±2.67 | 7.56±2.45 | 0 |
| Control drug 1 | 12.24±1.63 | 6.45±1.43 | 0 |
| The medicine group | 11.24±1.71 | 5.95±1.34 | 0 |
Experimental result shows that the blood sugar decreasing effect of this product obviously is better than acarbose, and blood glucose can be dropped to normal basically level; Hypoglycemic effect is better after adding Fructus Amomi Rotundus.
This shows that present technique has following advantage:
1, this compound preparation looses based on Rhizoma Acori Graminei, behind the interpolation Fructus Amomi Rotundus, and the better effects if of its treatment diabetes.
2, this compound recipe is added and subtracted according to the ultimate principle of Chinese medicine based on ancient prescription, and the novel formulation of exploitation is safe.
The specific embodiment
Embodiment one:
Radix Trichosanthis 60g, Rhizoma Acori Graminei 20g, Rhizoma Coptidis 10g, Fructus Amomi Rotundus 10g.Above-mentioned raw materials is added on together, pulverizes, pill, standby.This product has the obvious functions of blood sugar effect according to 50 overcoming usefulness for each person every day.
Embodiment two:
Radix Trichosanthis 20g, Rhizoma Acori Graminei 10g, Rhizoma Coptidis 10g, Fructus Amomi Rotundus 10g, Herba Pogostemonis 10g, Rhizoma Atractylodis 10g, Cortex Magnoliae Officinalis 10g, Semen Coicis 10g, Rhizoma Alismatis 10g.Above-mentioned raw materials is added on together, extracted 60 minutes with medicinal reflow of alcohol, filter and obtain extracting solution, be concentrated into the dried extractum 20g that obtains, encapsulated or tabletting gets final product.This product has the obvious functions of blood sugar effect according to 1 overcoming usefulness for each person every day.
Embodiment three:
Radix Trichosanthis 90g, Rhizoma Acori Graminei 1g, Rhizoma Coptidis 1g, Fructus Amomi Rotundus 1g, Herba Pogostemonis 4g, Semen Coicis 3g.Above-mentioned raw materials is added on together, extracted 60 minutes with medicinal reflow of alcohol, filter and obtain extracting solution, be concentrated into the dried extractum 20g that obtains, encapsulated or tabletting gets final product.This product has the obvious functions of blood sugar effect according to 5 overcoming usefulness for each person every day.
Embodiment four:
Radix Trichosanthis 10g, Rhizoma Acori Graminei 50g, Rhizoma Coptidis 2g, Fructus Amomi Rotundus 2g, Rhizoma Atractylodis 24g, Cortex Magnoliae Officinalis 12g.Above-mentioned raw materials is added on together, and medication water reflux, extract, 60 minutes is filtered and is obtained extracting solution, is concentrated into half of former medicine volume, obtains 50 milliliters of concentrated solutions.This product according to for each person every day 5 milliliters take, have the obvious functions of blood sugar effect.
Embodiment five:
Radix Trichosanthis 40g, Rhizoma Acori Graminei 20g, Rhizoma Coptidis 20g, Fructus Amomi Rotundus 10g, Cortex Magnoliae Officinalis 10g.Above-mentioned raw materials is added on together, and medication water reflux, extract, 60 minutes is filtered and is obtained extracting solution, is concentrated into half of former medicine volume, obtains 50 milliliters of concentrated solutions.This product according to for each person every day 20 milliliters take, have the obvious functions of blood sugar effect.
Claims (2)
1. the Rhizoma Coptidis compound preparation of the damp and hot tired spleen type diabetes of treatment is characterized in that comprising following raw materials by weight percent: Radix Trichosanthis 1～90%, Rhizoma Acori Graminei 0.1～60%, Rhizoma Coptidis 0.1～40%, Fructus Amomi Rotundus 0.1～40%, Semen Coicis 0～40%, Herba Pogostemonis 0～40%, Rhizoma Atractylodis 0～40%, Cortex Magnoliae Officinalis 0～40%, Rhizoma Alismatis 0～40%; Above-mentioned raw materials is added on together in proportion, is ground into the fine powder pill; Perhaps boiled 10～120 minutes with medicinal ethanol or decocting, filter and to obtain extracting solution, be concentrated into driedly, encapsulated or tabletting gets final product; Or described extracting solution is concentrated into 1/2 of raw material volume, sterilization bottling then.
2. the Rhizoma Coptidis compound preparation of treatment diabetes according to claim 1 is characterized in that preferred compositions is following raw materials by weight percent in the described preparation: Radix Trichosanthis 30～80%, Rhizoma Acori Graminei 5～40%, Rhizoma Coptidis 5～40%, Fructus Amomi Rotundus 5～40%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105476976A CN101982194B (en) | 2010-11-17 | 2010-11-17 | Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105476976A CN101982194B (en) | 2010-11-17 | 2010-11-17 | Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101982194A true CN101982194A (en) | 2011-03-02 |
| CN101982194B CN101982194B (en) | 2012-03-21 |
Family
ID=43619118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105476976A Expired - Fee Related CN101982194B (en) | 2010-11-17 | 2010-11-17 | Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101982194B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103053748A (en) * | 2012-12-31 | 2013-04-24 | 青岛华仁信息技术开发有限公司 | Kudzu vine root fat-reducing sugar-reducing health-care tea and preparation method thereof |
| CN106138701A (en) * | 2016-09-06 | 2016-11-23 | 湖南灼华生物科技有限公司 | A kind of Chinese medicine composition improving damp-heat stagnating in the spleen and its preparation method and application |
| CN113025707A (en) * | 2021-05-19 | 2021-06-25 | 北京中医药大学 | Application of biomarker in preparation of product for diagnosing damp-heat spleen-encumbering type 2 diabetes and kit |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066602A (en) * | 1992-05-08 | 1992-12-02 | 王德修 | The compound method of hypoglycemic compound capsule |
| CN101513474A (en) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | Chinese medicinal oral liquid for treating diabetes |
-
2010
- 2010-11-17 CN CN2010105476976A patent/CN101982194B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066602A (en) * | 1992-05-08 | 1992-12-02 | 王德修 | The compound method of hypoglycemic compound capsule |
| CN101513474A (en) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | Chinese medicinal oral liquid for treating diabetes |
Non-Patent Citations (1)
| Title |
|---|
| 《中国临床医生杂志》 20071231 董振华 从中医痰湿论治糖尿病 65-66 1-2 第35卷, 第06期 2 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103053748A (en) * | 2012-12-31 | 2013-04-24 | 青岛华仁信息技术开发有限公司 | Kudzu vine root fat-reducing sugar-reducing health-care tea and preparation method thereof |
| CN106138701A (en) * | 2016-09-06 | 2016-11-23 | 湖南灼华生物科技有限公司 | A kind of Chinese medicine composition improving damp-heat stagnating in the spleen and its preparation method and application |
| CN113025707A (en) * | 2021-05-19 | 2021-06-25 | 北京中医药大学 | Application of biomarker in preparation of product for diagnosing damp-heat spleen-encumbering type 2 diabetes and kit |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101982194B (en) | 2012-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742939B (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN101011561B (en) | Modern traditional Chinese medicine oral preparation huanglianwendan decoction and production method thereof | |
| CN102139084B (en) | Chinese medicinal composition for treating fatty liver and preparation method and application thereof | |
| CN102813801B (en) | Traditional Tibetan medicine for treating cough and preparation method thereof | |
| CN101485830A (en) | Pure Chinese medicine anti-aging health-care capsule | |
| CN102302563A (en) | Chinese medicinal composition for treating chronic kidney failure and preparation method thereof | |
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN115350242A (en) | Glycolipid metabolism regulator and preparation method and application thereof | |
| CN101011562B (en) | Novel formulation of shenqiwendan decoction and production method thereof | |
| CN101982194B (en) | Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN101524441A (en) | Chinese medicinal composition for lipid-lowering and weight-losing and preparation method thereof | |
| CN102416071A (en) | Medicinal composition with effect of treating insomnia, preparation method and application of medicinal composition | |
| CN104083602A (en) | Traditional Chinese medicine composition for treating respiratory tract infection and inflammation and preparation method thereof | |
| CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
| CN103735871A (en) | Chinese medicinal composition for treating neurasthenia and preparation method thereof | |
| CN103223024A (en) | Diabetes mellitus dialectical traditional Chinese medicine prescription | |
| CN105327181A (en) | Medicine composition for treating diabetes | |
| CN102846720B (en) | Composite for lowering blood fat and improving anoxia endurance | |
| CN1517115A (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
| CN101259205A (en) | Medicaments assembly for treating adiposis and preparation thereof | |
| CN100421706C (en) | Chinese medicinal composition for treating climacteric syndrome and its preparation method | |
| CN104306784A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis as well as preparation method and application thereof | |
| CN103961551A (en) | Traditional Tibetan medicine for treating diabetes | |
| CN101401908A (en) | Traditional Chinese medicine for reducing blood sugar, governing blood fat and anti-DNA damnification, and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120321 Termination date: 20141117 |
|
| EXPY | Termination of patent right or utility model |